'Under the radar success': 3 quality ASX 200 growth shares to buy right now
The market tilt towards ASX dividend payers may be sacrificing the growth that these gems provide, according to this expert.
Stay updated with breaking news from Pro Medicus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The market tilt towards ASX dividend payers may be sacrificing the growth that these gems provide, according to this expert.
Can the premium price of Pro Medicus Limited (ASX: PME) shares be validated, or is it time the bears had a field day with this ASX 200 beast?
Shares of Pro Medicus Limited (OTCMKTS:PMCUF – Get Rating) traded up 0.4% on Thursday . The stock traded as high as $42.69 and last traded at $42.69. 210 shares changed hands during mid-day trading, a decline of 71% from the average session volume of 734 shares. The stock had previously closed at $42.50. Analyst Upgrades […]
Shares in the SaaS-based medical imaging small cap have doubled over two trading sessions after it signed a five-year deal with a US hospital group.
Hoping to hunt down some ASX growth shares this month? Here are the ones our Foolish writers reckon could deliver sweet, long-term returns.